Lindsay Androski Featured Panelist on  BIO CEO & Investor Conference's Policy Outlook Panel

Written By Amanda Waldhauser

This February Lindsay Androski, RSV President and CEO, was featured at the 2024 Biotechnology Innovation Organization (BIO) CEO & Investor Conference on their panel, “Policy Outlook: Understanding the Environment for Pricing and Access to Medicines During an Election Year.” The session broke down this year’s policy outlook, focused on current hot topics in drug pricing and access to medicines, and examined how these issues are impacting biotech investments. 

Amanda Waldhauser
Previous

Increasing Impact: Leveraging Data to Drive Healthcare Access and Advancement 
Next

Amanda Waldhauser Featured Speaker at Access to Medicine Foundation's Session on Impact Investing